Table 2.
Author | Age (years) | Gender | Other metastases | Intracranial location | Survival (months) | Functional status | Brain metastasis from initial diagnosis |
---|---|---|---|---|---|---|---|
Seabold et al. (1977) [12] | 35 | F | Liver and lung | Brain | − | − | - |
Seabold et al. (1977) [12] | 54 | M | Liver | Brain | − | Non-functioning | 17 months |
Tartour et al. (1993) [13] | 60 | F | Liver, bone | Brain | − | − | - |
Kubota et al. (1997) [6] | 47 | M | Lung and liver | Brain | 3 | − | 9 months |
Bartley et al. (2001) [5] | 24 | M | Lung and vertebrae | Orbit/brain | 15 | Nonfunctioning | 2 years |
Ohwada et al. (2006) [8] | 43 | F | Lung, live, bone | Brain | 23.7 | Cushingoid | ~2 years |
Capone et al. (2009) [18] | 45 | M | Liver and lung | Brain, skull, meninges | 24 | Nonfunctioning | 6 months |
Velarde et al. (2015) [14] | 29 | F | Liver and lung | Brain | 2 | − | 3 years |
Velarde et al. (2015) [14] | 37 | M | Liver, lungs, lymph nodes | Brain | 8 | − | 3 years |
Velarde et al. (2015) [14] | 38 | F | Liver and lung | Brain | 12 | − | 6 years |
Velarde et al. (2015) [14] | 44 | M | Liver, bone, pleura | Brain | 7 | − | 6 years |
Velarde et al. (2015) [14] | 48 | F | Lung | Brain | − | − | 11 years |
Velarde et al. (2015) [14] | 60 | M | Lung | Brain | Lost to follow-up | − | 2 years |